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Abstract
Background: Preterm birth is the primary cause of the neonatal mortality and morbidity. There
will be no preterm birth without a cervical softening. Nitric oxide (NO) is shown to be a mediator
of term cervical ripening. The aim of this study was to investigate mRNA expression of the three
isomers of NO synthases (NOS) and to identify them by immunohistochemistry in the human
cervix at preterm birth compared to term.
Methods: The three isomers of NOS- inducible (iNOS), endothelial (eNOS) and neuronal (bNOS)
– were investigated in the human cervix. The expression of mRNA was determined using Real-
Time Multiplex RT-PCR. The localisation of synthases in the cervical tissue was analysed using
immunohistochemistry. Cervical biopsies were obtained from 4 groups of women without clinical
signs of infection: preterm (PTL), term labour (TL), preterm not in labour (PTnotL) and term not
in labour (TnotL) patients. One-Way ANOVA, Kruskal-Wallis, Student t-test or Mann-Whitney
test were applied as appropriate to determine statistically significant differences among the groups.
Results: Patients in preterm labour had significantly (p < 0.01) higher mRNA levels of all the three
NOS isomers compared to those in term labour. Women not in labour, irrespective of gestational
age, thus with unripe cervices, had significantly lower eNOS mRNA levels compared to those in
labour (p < 0.01). Immunoreactivity for all three NO synthases was observed in each examined
sample in all groups. The bNOS staining was the most prominent.
Conclusion: The mRNA levels were higher in the preterm labour group compared to the women
at term labour. The significant increase of the eNOS mRNA expression, from the unripe to the
favourable cervical state during labour, may indicate a role of eNOS and supports the role of NO
in the cervical ripening process. All the three synthases were identified by immunohistochemistry
in all the groups of study.
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Background
The frequency of premature birth has not changed signif-
icantly during the past two decades and the basic mecha-
nisms underlying the initiation of both preterm and term
cervical ripening and labour remain unknown [1]. No
effective treatment for preterm labour (PTL) that reduces
perinatal mortality and inhibits preterm delivery exists
[2]. To accomplish a preterm delivery the myometrial con-
tractions must be coordinated with a preterm ripening of
the cervix. The cervical remodelling detected clinically,
consists of softening, effacement and dilation. This corre-
sponds to vast changes in the extracellular matrix (ECM)
composition and tissue remodelling by proteolytic
enzymes [3,4]. The cervical ripening procedure is to be
considered an inflammatory reaction. The 100-fold
increase of interleukines is likely to be responsible for the
recruitment of leukocytes/influx of white blood cells trig-
gering the inflammatory process [1,5,6].
Many studies have revealed the importance of nitric oxide
(NO) as a major mediator in numerous biological proc-
esses in the human. NO controls the key elements that
enable reproduction and NO production is essential for
maintaining pregnancy [7]. It is synthesized by any of the
three NO synthases (NOS)- inducible (iNOS), endothe-
lial (eNOS) and neuronal (bNOS)- from the amino acid
L-arginine and oxygen to equal amounts of NO and citrul-
line [8]. Two of the NOS enzymes, bNOS and eNOS, are
constitutively expressed and calcium dependent. The third
enzyme, iNOS, is calcium independent and can be
induced by various cytokines. iNOS synthesizes NO in
large quantities during a long period of time [9]. bNOS
and eNOS occur in smaller amounts than the iNOS.
The role of NO as an inflammatory mediator in cervical
ripening is complex but seems to be important – NO has
been proposed to act as the final effector in this process
[10]. The results from earlier studies are conflicting, but all
three NO synthases have been identified in the human
cervix at term pregnancy [11-14]. NO amplifies the
cytokine cascade in acute inflammatory response [15].
Together with PGE2 and PGI it is the most potent vasodi-
lator and stimulates the matrix metalloproteinases
(MMPs) activity in the cervical tissue [15,16]. In 1997
Chwalisz and Garfield raised the theory that NO induced
local vascular permeability by leukocyte infiltration, acti-
vating MMPs and also modulating the proteoglycan syn-
thesis during the cervical remodelling [17]. Locally
administered NO-donors induce cervical ripening in
humans [18]. They have been found to enhance the COX-
2 enzyme activity which thereby up-regulates the prostag-
landin synthesis and leads to increased releases of PgE2
and PgF2α [19]. Prostaglandins may be the mediators of
NO-driven cervical ripening and dilation [1]. The cervical
bNOS protein expression has been shown to be signifi-
cantly higher at term labour (TL) compared to term not in
labour [12,14]. These data contradict the study by Led-
ingham et al. that could not show any increase of the
bNOS protein expression following the onset of labour
compared to the first trimester of pregnancy [13]. An
increased mRNA expression of iNOS has been registered
in cervical tissue at term labour compared to the non-
pregnant state [11]. A newly published study has shown
that the nitric oxide metabolite levels in cervical fluid in
women going beyond term was 4,5 times (p < 0.001)
lower that in women delivering at term [20].
To our knowledge, there are no studies so far investigating
NOS expression and localization in the in preterm cervical
ripening.
The purpose of our study was to investigate the mRNA
expression and protein localization of the three isomers of
NOS in human cervix during preterm birth, and to com-
pare it with the conditions at term. We therefore estimated
the mRNA expressions of bNOS, eNOS and iNOS, using




A total of 42 women undergoing singleton pregnancies
were included in the present study. The two preterm
groups included 15 women in preterm labour, (PTL) and
5 in preterm not in labour (PTnotL), delivered by caesar-
ean section before the onset of labour. Premature delivery
was defined as delivery before the 37th week of gestation.
Each preterm group was compared with the same group at
term: 14 women in term labour (TL) and 8 in term not in
labour caesarean section (TnotL). There were no signifi-
cant differences regarding maternal age, parity and previ-
ous preterm births between the four groups.
The labour groups were in active labour and demon-
strated a ripe cervix dilated > 4 cm. In all patients delivered
by caesarean section the assessment of cervical dilatation
was established immediately before surgery, by the same
obstetrician (SAT) through vaginal digital examination.
The women in preterm labour were either delivered vagi-
nally, or by emergency caesarean section due to malpre-
sentation. The women in term labour were also either
delivered vaginally or by emergency caesarean due to
threatening foetal asphyxia. Women not in labour had
unripe cervices (Bishop score <5p) and were delivered by
caesarean section before the onset of labour. The preterm
indications were suspected ablatio or intra-uterine growth
retardation and the term indications were breech presen-
tation, humanitarian or disproportion. The patients with
pre-eclampsia, diabetes or other systemic diseases were
excluded from the study. In all women clinical signs ofReproductive Biology and Endocrinology 2005, 3:33 http://www.rbej.com/content/3/1/33
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infection were absent, during parturition as well as during
the postpartal period.
This study was performed after receiving the approval of
the local Ethics Committee of the Karolinska Institute
(Ref. No. 97-089) and the informed consent of each
subject.
Immediately following parturition, a biopsy from the
anterior cervical lip was taken transvaginally (at the 12
o'clock position) with scissors and tweezers. Our group
has since 25 years applied this technique to get samples
including squamous and cylindrical epithelium, vessels,
glands and ECM. These samples were immediately frozen
in liquid nitrogen and stored thereafter at -70°C.
Due to the limited amount of tissue from each woman, all




Using Trizol reagent total RNA was extracted from the fro-
zen biopsies [21,22].
DNAse treatment
DNA contamination was minimized by DNAse-I (Cat. #
2222, Ambion Inc., Austin, TX, USA) treatment.
Concentrations of total RNA were determined by meas-
urements of the OD260  using a spectrophotometer
(DU64®, Beckman, Palo Alto, CA, USA). Only samples
with an OD260/OD280 ratio between 1.75 and 2.1 were
used for RT-PCR.
Real-Time Multiplex RT-PCR
The cDNA sequences of human iNOS, eNOS, and bNOS
were obtained from the Entrez Nucleotide Database http:/
/www.ncbi.nlm.nih.gov/entrez/; database accession num-
bers are shown in table 1). Specific primers and Taqman®
probes were designed using Primer Express®  software
(AppliedBiosystems; primers and probes are shown in
table 1). Alignment to other known human genes was
excluded by running a BLAST http://
www.ncbi.nlm.nih.gov/BLAST/.
The experiments were carried out using the ABI Prism®
7700 Sequence Detection system (TaqMan®) from
AppliedBiosystems (Foster City, CA, USA).
The conditions for multiplex RT-PCR were optimised and
performed as follows (all products from AppliedBiosys-
tems Inc., Foster City, CA, USA) with the expression of
ribosomal RNA serving as internal standard:
1× TaqMan Buffer, 5.5 mM MgCl2, 300 µM dATP, 300 µM
dCTP, 300 µM dGTP, 600 µM dUTP, 1.25 U AmpliTaq
Gold DNA Polymerase (TaqMan PCR Core Reagent Kit,
Part # N808-0228), 25 nM ribosomal RNA FWD-Primer,
REV-Primer, and probe (Part # 4308329), 20 U RNAse
inhibitor (Part # N808-0119), 12.5 U MultiScribe Reverse
Transcriptase (Part # 4311235). The target RNA primer
and probe concentrations used are displayed in table 1.
Reverse transcription was performed at 48°C (30 min)
followed by thermal activation of the DNA polymerase
(95°C, 10 min). PCR was carried out running 50–60
cycles (denaturing: 95°C [15 s]; annealing: 60°C [1
min]).
Table 1: Description of primers and probes used for Real-time RT-PCR. Accession number (Entrez Nucleotide Database), sequences 
of primers and probes for human iNOS, eNOS, and bNOS; optimal primer and probe concentrations; number of PCR-cycles.
Target Accession # Type Sequence Concentration (nM) N cycles
iNOS XM_034166 FWD TGGATGCAACCCCATTGTC 300 60
REV CCCGCTGCCCCAGTTT 50
Probe 6FAM-TCCCCACGGCATGTGAGGATCA-TAMRA 200
eNOS AF400594 FWD CGGCATCACCAGGAAGAAGA 300 50
REV CATGAGCGAGGCGGAGAT 300
Probe 6FAM-TTCACGGCGTTGGCCACTTCTTTAAA-TAMRA 200
bNOS NM_000620 FWD GGATCACATGTTCGGTGTTCAG 300 50
REV CCCAACTTTGCGCTTGAAGA 900
Probe 6FAM-AAATCCAGCCCAATGTCATTTCTGTTCG-TAMRA 200Reproductive Biology and Endocrinology 2005, 3:33 http://www.rbej.com/content/3/1/33
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The threshold cycles (CT), at which an increase in reporter
fluorescence above the baseline signal could first be
detected, were determined.
The relative amounts of target RNA were normalized to
the amounts of ribosomal RNA using the Comparative
(∆∆CT) Method according to the TaqMan User Bulletin
#2.
Immunohistochemistry
Due to small size of the biopsies, immunohistochemistry
analyses were carried out in only two samples in each
study group.
Frozen sections, 8 µm thick, were mounted onto gel chro-
matin-coated glass slides. The sections were fixed in 2%
paraformaldehide in phosphate-buffered saline (PBS), pH
7.4, during 20 minutes, washed in PBS, and then air-dried
and stored at -20° until analysis. Tissue sections were
stained using the avidin-biotinylated (ABC)-peroxidase
complex method. When analysed they were rewashed in
PBS for three times five minutes. The endogenous peroxi-
dase activity was eliminated by pre-treatment with 0.3%
hydrogen peroxide in methanol for 30 minutes followed
by washing in PBS/BSA (0,05%).
The slides were incubated over night with the primary
mouse monoclonal antibodies for iNOS, eNOS and
bNOS 5 ug/ml (Transduction Laboratories, Lexington,
Kx) in PBS containing 0,05% bovine serum albumin. Sub-
sequently the sections were directly incubated with the
secondary antibody (horse anti-mouse) diluted in block-
ing sera. The sections were washed with PBS/BSA, incu-
bated with ABC-complex for 45 minutes, and then
rewashed in PBS/BSA. The reaction was developed using
the DAB-kit (diaminobenzidine) from Vector (Burlin-
game, CA, USA). The slides were then rinsed in distilled
water. Counterstaining was performed with 10% Mayer's
Haematoxylin for 3–4 minutes, thereafter the sections
were washed in water. For control, sections were stained
as above, omitting the primary antibody. The slides were
finally mounted with glycerolgelatin. For all immunohis-
tochemical examinations the immunoreactivity was
checked in the squamous epithelium, the glandular epi-
thelium, the stroma and the vascular endothelium. The
slides were classified by three independent observers
using light-microscopy. Staining was localized but no
attempt was made to quantify staining in the different
groups.
Statistical analysis
Outliers were removed according to Chauvenet's crite-
rion. Data were then checked for normality. One-Way
ANOVA followed by multiple pairwise comparisons (Tur-
key) was performed to determine differences among the
groups when the data was normally distributed; when
data was not normally distributed, Kruskal-Wallis One-
Way ANOVA followed by multiple pairwise comparisons
(Dunn's) was used. For comparison of only 2 groups, t-
test or Mann-Whitney U-test were used as appropriate. A




Real-Time Multiplex RT-PCR confirmed the presence of
mRNA for each of the three NOS isoforms within all
biopsies.
iNOS
In general, iNOS mRNA levels were low in most of our
cervical samples.
Patients who delivered preterm had higher iNOS mRNA
levels compared to those who delivered at term. This rela-
tionship reached significance for the patients in labour (p
= 0.002) (Fig. 1)
eNOS
Significantly higher eNOS mRNA levels were registered in
the preterm labour group when compared with the term
labour group (p = 0.009).
The two groups of patients with unripe cervices, thus the
preterm and term not in labour groups, had significantly
lower eNOS mRNA levels compared to the respective
labouring groups (PTnotL vs. PTL [mean ± SEM]: 25.9 ±
4.8 vs. 100.0 ± 10.8, p < 0.001; TnotL vs. TL [mean ± SEM]:
28.1 ± 4.5 vs. 58.5 ± 5.2, p = 0.48) (Fig. 1).
bNOS
The lowest bNOS mRNA levels were seen in women at
term labour (TL [mean ± SEM]: 23.1 ± 6.4). Women who
delivered preterm generally had higher bNOS mRNA lev-
els compared to those delivered at term, reaching signifi-
cance in the group of patients in labour (PTL vs. TL [mean
± SEM]: 128.2 ± 32.6 vs. 23.1 ± 6.4, p = 0.006) (Fig. 1).
Also women who were delivered by caesarean section
appeared to have higher bNOS mRNA levels than those
who were in labour, reaching significance in the term
groups (TnotL vs. TL [mean ± SEM]: 67.8 ± 16.4 vs. 23.1 ±
6.4, p = 0.007) (Fig. 1).
Immunohistochemistry
As earlier mentioned, only two samples were examined
from each group due to shortness of the material. All three
isoenzymes were identified and localized in all samples.
The negative control sections for each of the synthases
showed no staining. Although, it was not possible to doReproductive Biology and Endocrinology 2005, 3:33 http://www.rbej.com/content/3/1/33
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quantification of immunoreactivity, but there are some
observations we want to focus upon.
iNOS was found in the epithelium in many of the samples
and some iNOS was found in the stroma in all study
groups (Fig. 2). There was only one sample showing iNOS
in the vascular endothelium or in the glandular cells.
eNOS was constitutively and prominently expressed in
the vascular endothelium in all groups without any visual
differences between labouring and non-labouring groups
(Fig. 2).
bNOS showed the most impressive staining of the three
isoenzymes, localized to the stroma, the glandular epithe-
lium and the basal membrane of the squamous epithe-
lium. The stromal localization was predominant. The
visual impression was that bNOS was more expressed in
the labouring groups (Fig. 2).
Discussion
Despite intense research over the years, the complex, but
well coordinated mechanisms that control the onset and
maintenance of labour remains unrevealed [1,23-25].




Expression of mRNA of NOS isomers in the cervical tissue Figure 1
Expression of mRNA of NOS isomers in the cervical 
tissue. Expression of NOS mRNA normalized to the 'Pre-
term labour' group. Common superscripts indicate no signifi-
cant differences. The number of patients analysed in each 
group are marked in each bar in the bar chart. The groups 
are: Preterm labour (PTL), Term labour (TL), Preterm not 
in labour, (PTnotL), Term not in labour, (TnotL). 
1A:Expression of iNOS mRNA: Patients who delivered 
preterm had higher iNOS mRNA levels compared to those 
who delivered at term. This relationship reached significance 
for those who were in labour (p < 0,002). 1B: Expression 
of eNOS mRNA: Significantly higher levels of eNOS 
mRNA were registered in women with preterm labour com-
pared to term labour (p = 0,009). Women not in labour at 
preterm and at term had significantly lower eNOS mRNA 
levels compared to preterm labour (p < 0,001) or term labor 
(p = 0,048) respectively. 1C: Expression of bNOS mRNA 
: Women who delivered preterm had generally higher bNOS 
mRNA levels compared to those who delivered at term, 
reaching significance in the labour group (p = 0,006). The 
lowest values were seen in those who were in labour at 
term. Women who were delivered by caesarean section 
appeared to have higher bNOS mRNA levels than those who 
were in labour, reaching significance in the term groups (p = 
0.007).Reproductive Biology and Endocrinology 2005, 3:33 http://www.rbej.com/content/3/1/33
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Immunohistochemical localization of nitric oxide synthases in human cervix Figure 2
Immunohistochemical localization of nitric oxide synthases in human cervix. (a) inducible nitric oxide (iNOS) local-
ized to the stroma in preterm labour (b) iNOS localized to the squamous epithelium in preterm not in labour patient. In each 
of the biopsies iNOS was localized in the stroma and the epithelium. (c) Endothelial nitric oxide (eNOS) localized to the vas-
cular endothelium in all biopsies. This is collected from a woman in preterm labour. Neuronal nitric oxide (bNOS) had a dis-
tinct staining and was generally localized to the: (d) basal membrane of the squamous epithelium, picture from a women in 
preterm labour, (e) the stroma, biopsy from at term in labour patient, (f) the cervical glands, this sample from at term in 
labour patient. Original magnification × 200, scale bar 50 µm.Reproductive Biology and Endocrinology 2005, 3:33 http://www.rbej.com/content/3/1/33
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been focused upon the myometrial activities and on
potential inhibitors of preterm labour.
To our knowledge, this is the first study investigating NOS
isomers expression in preterm cervix.
Our hypothesis is that a cervical remodelling occurs at
preterm delivery as well as at term. It seems relevant to
believe that a woman going into preterm labour starts
from a relatively more unripe cervical status than a
woman going into labour near or at term [26]. To achieve
this more extensive remodelling from a very unripe cervi-
cal state, higher level of iNOS, eNOS and bNOS mRNA at
preterm would be relevant. Here we analyse biopsies from
women with preterm parturition without any signs of
infection. We identified the presence of all three NOS iso-
mers mRNA in preterm and term cervix before and after
onset of labour. The most prominent finding was higher
mRNA levels in preterm labour compared to term labour.
The eNOS mRNA level was significantly higher for the
preterm group in labour compared to all other groups.
The eNOS mRNA levels in the women not in labour, thus
with unripe cervices, were significantly lower compared to
those in labour irrespective of gestational age. These
results may indicate a role for eNOS in the very final cer-
vical ripening both preterm and term.
The iNOS mRNA levels were generally low in all groups,
exhibiting the lowest value in the term labour group and
the highest value in the preterm labour group. We have
only found two earlier studies analysing iNOS and eNOS
mRNA levels in human pregnant cervix [11,27]. Tschug-
guel et al. noted higher iNOS mRNA levels in the postpar-
tum group compared to non-pregnant controls while
Yoshida et al [27] identified both iNOS and eNOS mRNA
in the first trimester cervix. In the study by Ledingham et
al. labouring and non labouring patients were compared
at term pregnancy and the protein expression was exam-
ined by Western blot and immunohistochemistry without
any differences of the three synthases, iNOS, eNOS and
bNOS, being found [13]. These different results reveal the
complex story of human labour as compared to the more
uniform process described in other species [7,28].
Our results showed bNOS mRNA levels to be higher in the
preterm compared to the term groups. Women in preterm
labour had significantly higher bNOS mRNA levels com-
pared to the same group at term. Interestingly, when com-
paring labour and not in labour groups in preterm and
term patients respectively, we found that the groups not in
labour had higher bNOS mRNA expression levels. This is
in contrast to the study of Bao et al. where an upward
trend of bNOS mRNA by RT-PCR during labour com-
pared to not in labour was noticed.
The immunoreactivity of the NO synthases had different
localization. iNOS was identified in the stroma and in the
epithelium. This is in line with earlier findings [11,14,27].
On the other hand we only found iNOS localised to the
vascular endothelium in very few sections whereas
Ledingham et al. showed iNOS protein localized to the
vascular endothelium more generally [13]. The differ-
ences observed may be due to the fact that Ledingham et
al. used paraffin-embedded sections of cervical tissue
while we in our study, just as Tschugguel et el. and Yosh-
ida et al. used cryosections. The eNOS specific staining
was localized to the endothelium in all groups, which is
supported by earlier investigations [11,13,14,27].
bNOS showed the most impressive immunoreactivity in
our study. It was localised to the stroma, the glandular
epithelium and to the basal membrane of the squamous
epithelium. These observations agree with earlier findings
by Bao et al. namely studies on cervical tissue from non-
pregnant and pregnant women [12]. Our data differs from
that of Ledingham et al. who could not identify bNOS in
the cervical glands [13]. Tschugguel et al could not iden-
tify any bNOS at all in the cervical tissue, but this may be
due to the fact that they used a polyclonal antibody, while
we used a monoclonal antibody [11].
A possible concern regarding the immunohistochemistry
analysis is that the interpretation of the localization of the
different NO synthases might have been more reliable if a
greater number of biopsies had been studied. Due to a
shortage of material only two biopsies from each of the
four groups were analysed in this study.
In this study we endeavoured to include women without
any clinical signs of infection, neither during labour/
delivery nor during the postpartum period. However, it is
well known that a systemic or intrauterine infection can
cause a preterm delivery and labour [29]. In those cases
studies often shows increased cytokine response and up-
regulation of the synthesis of cytokines compared to term
non infected labour. In Sweden only around 25 % – at a
maximum – of the preterm births seems to have an infec-
tious genesis, but in other parts of the world, infection is
estimated to be associated with preterm labour/delivery in
as much as 40% of the cases [30]. Infection as causal to
preterm labour and delivery is more frequent the lower
the gestational age as well as in preterm premature rupture
of membranes [31].
A new enigma based on earlier findings by our group and
others is that a significant up-regulation of inflammatory
parameters, cytokines, chemokines and MMPs are seen
also in normal vaginal labour at term where no infection
is present [1,11,32-35].Reproductive Biology and Endocrinology 2005, 3:33 http://www.rbej.com/content/3/1/33
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It is well known that cytokines, chemokines, different
MMPs, prostaglandins, Cyclooxygenas (COX) and NO are
inflammatory mediators. The extensive infiltration of
immune cells as leukocytes, neutrophils and macrophages
into the cervical stroma produce pro-inflammatory
cytokines and collagenases that promote and accelerate
the degradation of the ECM. The actions of prostaglandins
and nitric oxide are activated by these cascade reactions
and leads to the fully ripened cervix and induction of
labour [5,19,22,32,33,36-38].
Nitric oxide donors are potent cervical ripeners and the
up-regulation of NO by the proinflammatory cytokines is
proposed to represent the final common pathway of cer-
vical ripening [7,10,15,18-20]. NO directly stimulates
COX-II and together with the increase of the proinflam-
matory cytokines IL-1, TNF-alpha and IL-8 results is
increased prostaglandin production.
The increased amount of macrophages is associated with
enhanced iNOS activity [13]. A strong expression of bNOS
protein and mRNA in the cervical stroma at term com-
pared to that of non-labouring or non-pregnant state is
also seen [12,39].
This study revealed a frequent occurrence of bNOS in the
cervix during pregnancy and labour, which is in agree-
ment with our earlier findings that the cervix, in contrast
to the uterus, is well innervated during pregnancy and
labour. The immune-related cervical ripening process may
be regulated by neural signalling by different neurotrans-
mitter [40,41]. Yellon et al. also raised the question why
antibiotic treatment has failed to either prolong labour or
reduce the rate of preterm birth. Taking into account the
theory that the cervical remodelling consists of inflamma-
tory immune cell activation it is logical that antibiotics
have no effect, as they do not affect immune cell
trafficking. It thus seems plausible that the rapid final cer-
vical ripening is not related to an exogenous infection but
is instead a part of a physiological inflammatory reaction.
Such a process has been registered in the endometrium
during menstruation as well as in the uterus at involution
postpartum [25,42,43].
Conclusion
All the three isomers of NOS were identified in human
cervix at preterm. The mRNA expression of the NOS iso-
mers was significantly higher in the preterm group in
labour compared to the women at term labour. Further-
more, the eNOS mRNA level was significantly higher dur-
ing labour compared to not in labour irrespective of
gestational age, which may indicates a potential role of
eNOS in the very final cervical ripening.
In conclusion, our results show differences in the preterm
and term mRNA expression of NOS. Further studies on
preterm patients with infections are motivated, to eluci-
date the possible differences in NO expression in PTL with
infectious genesis compared to idiopathic PTL.
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